TABLE 3.

ADVERSE EVENTS IN THE RESOLVE TRIAL BASED ON IL-8 STRATIFICATION

	IL-8 ≤ 220 pg/ml (n = 72)	IL-8 > 220 pg/ml (n = 121)	P Value
Serious adverse events, n (%)
Day 0 to 6	5 (6.9)	11 (9.1)	0.6*
Day 0 to 28	12 (16.7)	21 (17.4)	0.9*
Serious bleeding events, n (%)
Day 0 to 6	0 (0)	4 (3.3)	0.3†
Day 0 to 28	1 (1.4)	9 (7.4)	0.09†
Serious bleeding events, n (%)
Day 0 to 6	0 (0)	0 (0)	—
Day 0 to 28	1 (1.4)	4 (3.3)	0.6†

^*χ².

^†Fisher exact test.